Page 2 - Pathogen Readiness News Today

  At a glance: New study shows that viral rebound with Paxlovid is more common than previously believed. Clinicians should counsel patients about the possible risk of transmitting virus during rebound. A new study by Harvard Medical School researchers at Massachusetts General Hospital and Brigham and Women’s Hospital has found that one in five individuals […]

Though antivirals are critical for reducing severe COVID-19 symptoms, researchers suggested that the medication may not always be needed for milder cases.

Chair, Department of Virology, Immunology & Microbiology job in Boston, Massachusetts with BU Chobanian & Avedisian School of Medicine - Virology, Immunology, and Microbiology Department. Apply Today.

A novel coronavirus would come to affect every ward, clinician, researcher and patient at Massachusetts General Hospital.

  Application Deadline: March 31 Harvard Medical School and the Massachusetts Consortium on Pathogen Readiness will host a two-day educational immersion for reporters June 8-9. The event will bring together a small group of medical and science journalists and preeminent researchers and physician-scientists for a two-day seminar on the Harvard Medical School campus in Boston.

SARS-CoV-2 keeps changing. What does this mean for the treatment of COVID-19?

More free at-home COVID tests are part of the White Houses plan to combat rising cases this winter season.

Experts are predicting COVID cases in China will explode after the country ended its strict zero-COVID policy. Heres how the US may be affected.

Experts are predicting COVID cases in China will explode after the country ended its strict zero-COVID policy. Heres how the US may be affected.

Biden administration announces new efforts to reduce COVID-19 as cases rise after Thanksgiving holiday. Will provide more tests, shots and treatments.